SEC Form 4 · accession 0001091596-19-000006
Nuo Therapeutics, Inc. · AURX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lawrence Atinsky
Director
Period of report
Dec 31, 2018
Accepted (ET)
Jan 3, 2019 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001091596
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $0.40 | Dec 31, 2018 | A | 62,500 | A | Dec 31, 2018 | Dec 31, 2025 | COMMON STOCK | 62,500 | 62,500 | D |
Explanation of responses
- F1The Reporting Person, a partner at Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities.